Showing results (41-50 of 249) with videos related to
Sort By:
Pageof 25
European Journal of Gastroenterology & Hepatology|May 20, 1999
Effect of radiation therapy on the potential doubling time of tumours in colorectal cancersP Michel, M Paresy, F Lepessot, et al.Cancer Investigation|January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group studyH Bleiberg, B Vanderlinden, M Buyse, et al.Analytical and Bioanalytical Chemistry|November 19, 2003
Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometryGraham Lappin, R Colin GarnerNature Reviews. Drug Discovery|March 4, 2003
Big physics, small doses: the use of AMS and PET in human microdosing of development drugsGraham Lappin, R Colin GarnerExpert Opinion on Drug Metabolism & Toxicology|August 23, 2006
The use of accelerator mass spectrometry to obtain early human ADME/PK dataGraham Lappin, R Colin GarnerExpert Opinion on Drug Metabolism & Toxicology|December 2, 2008
The utility of microdosing over the past 5 yearsGraham Lappin, R Colin GarnerAlimentary Pharmacology & Therapeutics|July 5, 2006
Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancerS Lecleire, F Di Fiore, E Ben-Soussan, et al.Bulletin Du Cancer|March 1, 1993
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]T Conroy, J Wils, B Paillot, et al.Presse Medicale (Paris, France : 1983)|February 22, 1986
[Epidemiology of cancer of the pancreas. Current data]P Czernichow, E Lerebours, R ColinThe Gerontologist|November 27, 2002
Burden and well-being among caregivers: examining the distinctionNeena L Chappell, R Colin ReidPageof 25